Aflatoxin B(1) inhibits the type 1 interferon response pathway via STAT1 suggesting another mechanism of hepatocellular carcinoma

por Narkwa, Patrick W., Blackbourn, David J., Mutocheluh, Mohamed
Publicado 2017

Risk factors associated with hepatitis B exposure and the reliability of five rapid kits commonly used for screening blood donors in Ghana

por Mutocheluh, Mohamed, Owusu, Michael, Kwofie, Theophilus B, Akadigo, Tahiru, Appau, Emmanuel, Narkwa, Patrick W
Publicado 2014

Cryptolepine inhibits hepatocellular carcinoma growth through inhibiting interleukin-6/STAT3 signalling

por Domfeh, Seth A., Narkwa, Patrick W., Quaye, Osbourne, Kusi, Kwadwo A., Awandare, Gordon A., Ansah, Charles, Salam, Alimatu, Mutocheluh, Mohamed
Publicado 2021

The Pharmacologically Active Alkaloid Cryptolepine Activates a Type 1 Interferon Response That Is Independent of MAVS and STING Pathways

por Domfeh, Seth A., Narkwa, Patrick W., Quaye, Osbourne, Kusi, Kwadwo A., Addy, Bright S., Lant, Sian, Sumner, Rebecca P., Maluquer de Motes, Carlos, Awandare, Gordon A., Ansah, Charles, Mutocheluh, Mohamed
Publicado 2022